Clinical Trial

Societal Burden Associated With Type 1 Diabetes in Canada

Study acronym: T1D

Terminated

View on ClinicalTrials.gov →

Why the trial stopped

Recruitment.

Summary

The purpose of this observational study is to estimate the burden of T1D on caregivers of patient with T1D in terms of work productivity, healthcare resource utilization and quality of life.

Protocol Amendment History 5 changes

critical Trial terminated 2026-07-31

critical Trial terminated: Recruitment. 2026-07-31

notable Enrollment reduced: 100 -> 33 participants 2026-07-31

notable Primary completion pushed: 2025-12 -> 2026-07-20 2026-07-31

minor Completion pushed: 2025-12 -> 2026-07-20 2026-07-31

Trial Details

NCT Number	NCT06786130
Lead Sponsor	PeriPharm Collaborators: Sanofi
Conditions	Type 1 Diabetes Mellitus, Quality of Life (QOL), Work Productivity, Caregiver Subjective Burden
Enrollment	33 participants
Start Date	2025-01-09
Primary Completion	2026-07-20 (estimated)
Study Completion	2026-07-20 (estimated)
Updated on ClinicalTrials.gov	2026-07-30